152 related articles for article (PubMed ID: 15126329)
1. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
4. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
[TBL] [Abstract][Full Text] [Related]
5. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
[TBL] [Abstract][Full Text] [Related]
6. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
[TBL] [Abstract][Full Text] [Related]
7. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Zhou G; Tsai CW; Liu JO
J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
[TBL] [Abstract][Full Text] [Related]
8. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
Endo H; Takenaga K; Kanno T; Satoh H; Mori S
J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
[TBL] [Abstract][Full Text] [Related]
9. Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors.
Towbin H; Bair KW; DeCaprio JA; Eck MJ; Kim S; Kinder FR; Morollo A; Mueller DR; Schindler P; Song HK; van Oostrum J; Versace RW; Voshol H; Wood J; Zabludoff S; Phillips PE
J Biol Chem; 2003 Dec; 278(52):52964-71. PubMed ID: 14534293
[TBL] [Abstract][Full Text] [Related]
10. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
[TBL] [Abstract][Full Text] [Related]
11. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
[TBL] [Abstract][Full Text] [Related]
12. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis.
Kass D; Bridges RS; Borczuk A; Greenberg S
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):193-201. PubMed ID: 17446530
[TBL] [Abstract][Full Text] [Related]
13. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
[TBL] [Abstract][Full Text] [Related]
15. The C. elegans methionine aminopeptidase 2 analog map-2 is required for germ cell proliferation.
Boxem M; Tsai CW; Zhang Y; Saito RM; Liu JO
FEBS Lett; 2004 Oct; 576(1-2):245-50. PubMed ID: 15474045
[TBL] [Abstract][Full Text] [Related]
16. A chemical and genetic approach to the mode of action of fumagillin.
Zhang Y; Yeh JR; Mara A; Ju R; Hines JF; Cirone P; Griesbach HL; Schneider I; Slusarski DC; Holley SA; Crews CM
Chem Biol; 2006 Sep; 13(9):1001-9. PubMed ID: 16984890
[TBL] [Abstract][Full Text] [Related]
17. Antiparasitic activities of novel, orally available fumagillin analogs.
Arico-Muendel C; Centrella PA; Contonio BD; Morgan BA; O'Donovan G; Paradise CL; Skinner SR; Sluboski B; Svendsen JL; White KF; Debnath A; Gut J; Wilson N; McKerrow JH; DeRisi JL; Rosenthal PJ; Chiang PK
Bioorg Med Chem Lett; 2009 Sep; 19(17):5128-31. PubMed ID: 19648008
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
[TBL] [Abstract][Full Text] [Related]
20. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.
Kass DJ; Rattigan E; Kahloon R; Loh K; Yu L; Savir A; Markowski M; Saqi A; Rajkumar R; Ahmad F; Champion HC
PLoS One; 2012; 7(4):e35388. PubMed ID: 22509410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
